Results 91 to 100 of about 1,039 (178)

Effectiveness of Enhanced External Counterpulsation Treatment on Symptom Burden, Medication Profile, Physical Capacity, Cardiac Anxiety, and Health-Related Quality of Life in Patients With Refractory Angina Pectoris

open access: yes, 2020
BACKGROUND: Patients with refractory angina pectoris experience recurrent symptoms that limit their functional capacity, including psychological distress and impaired health-related quality of life (HRQoL), despite optimized medical therapy.
Desta, Liyew,   +7 more
core   +1 more source

Enhanced external counterpulsation for the treatment of stable angina and heart failure: a systematic review and economic analysis

open access: yesHealth Technology Assessment, 2009
Objectives: To determine the clinical effectiveness and cost-effectiveness of enhanced external counterpulsation (EECP) compared with usual care and placebo for refractory stable angina and heart failure, and to undertake analyses of the expected value ...
C McKenna   +9 more
doaj   +1 more source

Enhanced External Counterpulsation for the relief of angina in patients with diabetes: Safety, efficacy and 1-year clinical outcomes

open access: yes, 2003
Background: Patients with diabetes are at greater risk for coronary events, yet they are less likely to benefit from revascularization than those without diabetes.
Nesto, Richard W.   +4 more
core   +1 more source

Influence of enhanced external counterpulsation on endothelial function: a meta-analysis of randomized controlled trials

open access: yes, 2023
Enhanced external counterpulsation (EECP) is an effective and noninvasive treatment for patients with refractory angina and chronic heart failure. However, previous studies evaluating the influence of EECP on endothelial function showed inconsistent ...
Qiulin Yin (17280486)   +6 more
core   +1 more source

Current use of enhanced external counterpulsation and patient selection

open access: yesClinical Cardiology, 2002
Most patients who receive enhanced external counterpulsation (EECP) have symptomatic coronary artery disease. These patients have either responded poorly to pharmacologic therapy or are poor candidates for revascularization procedures. Such patients receive a variety of consistent benefits from EECP treatment.
openaire   +3 more sources

Treatment of chronic heart failure in the 21st century: A new era of biomedical engineering has come

open access: yesChronic Diseases and Translational Medicine, 2019
Chronic heart failure (CHF) is a challenging burden on public health. Therapeutic strategies for CHF have developed rapidly in the past decades from conventional medical therapy, which mainly includes administration of angiotensin-converting enzyme ...
Chun-Song Hu   +3 more
doaj   +1 more source

Enhanced external counterpulsation in acute coronary syndrome, as a part of the pre-coronary artery bypass surgery treatment

open access: yes, 2011
The continuous increase in the numbers of coronary heart disease (CHD) patients warrants the search for the new therapeutic approaches, which could be used when the standard methods are contraindicated or ineffective.
N. V. Belokopytova   +3 more
core   +1 more source

Enhanced External Counterpulsation

open access: yesJournal of the American College of Cardiology, 2006
O’Rourke, Michael F.   +1 more
openaire   +2 more sources

Enhanced external counterpulsation does not alter arterial stiffness in patients with angina

open access: yes, 2004
Background: Enhanced external counterpulsation (EECP) is a noninvasive treatment for angina that acutely augments diastolic pressure and reduces cardiac afterload.
F Dockery (16162175)   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy